47.73.Z - Retail sale of pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.78.Z - Retail sale of other new products
47.91.Z - Intermediary retail sale, non-specialized
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,5 | 0,5 | 0,5 | 12,1 |
Gross profit (loss) | 0,8 | 0,5 | 0,6 | 23,4 |
EBITDA | 0,9 | 0,6 | 0,7 | 19 |
Short time liabilities | 2,4 | 3,3 | 3,7 | 13,4 |
Other operating costs | 0 | 0 | 0 | -6,8 |
Equity capital | 0,3 | 0 | 0,2 | 725,1 |
Operating profit (EBIT) | 0,8 | 0,5 | 0,6 | 23,4 |
Assets | 3 | 3,5 | 4 | 16,9 |
Net profit (loss) | 0,8 | 0,5 | 0,6 | 23,4 |
Cash | 0,6 | 0,5 | 0,6 | 18,3 |
Net income from sale | 17,9 | 22,3 | 24,9 | 12 |
Liabilities and provisions for liabilities | 2,7 | 3,4 | 3,8 | 11,7 |
Working assets | 2,8 | 3,3 | 4 | 19,1 |
Other income costs | 0,3 | 0 | 0 | 73 942,9 |
Depreciation | 0,1 | 0,1 | 0,1 | 0 |
% | % | % | p.p. | |
Profitability of capital | 265,7 | 1761,7 | 263,5 | -1498,2 |
Equity capital to total assets | 10,1 | 0,7 | 5,2 | 4,5 |
Gross profit margin | 4,4 | 2 | 2,2 | 0,2 |
EBITDA Margin | 5 | 2,5 | 2,7 | 0,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 49 | 54 | 55 | 1 |
Current financial liquidity indicator | 1.1517184972763062 | 1.0149176120758057 | 1.0658364295959473 | 0,1 |
Net dept to EBITDA | -0.41677045822143555 | -0.8374578356742859 | -0.9391064047813416 | -0,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane